Aster DM Healthcare promoters have reduced their share pledge from 99 per cent to 41 per cent after completing a debt refinancing transaction with global financial institutions. This move aligns with the company’s stated strategy and strengthens its financial position.
As part of the refinancing process, JP Morgan, HSBC, and Barclays provided fresh funding, allowing Aster DM Healthcare promoters to refinance existing loans under improved terms and loan-to-value (LTV) ratios.
Dr Azad Moopen, Founder and Chairman of Aster DM Healthcare, stated, “The reduction in Aster’s pledged shares is a significant testament to our financial strength as promoters, especially in light of the volatile global market conditions. It reflects the strong confidence we have in our company’s growth trajectory, operational excellence, and strategic direction. This milestone also reinforces trust among our stakeholders, investors, and partners as we continue to expand our footprint in India.”
The refinancing transaction is expected to support Aster DM Healthcare’s financial strategy and growth plans in its key markets.
